http://goldenbergheller.com Thu, 03 May 2012 17:48:40 +0000 hourly 1 http://wordpress.org/?v=3.0.1 http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-119 The FDA investigation into Pradaxa Side Effects | Goldenberg Heller Antognoli & Rowland Mon, 19 Mar 2012 13:03:31 +0000 http://goldenbergheller.com/?page_id=1000#comment-119 [...] After recent reports of serious bleeding events and deaths in patients taking Pradaxa, the U.S. Food and Drug Administration (FDA) is now investigating Pradaxa and its potentially deadly side effects. [...] [...] After recent reports of serious bleeding events and deaths in patients taking Pradaxa, the U.S. Food and Drug Administration (FDA) is now investigating Pradaxa and its potentially deadly side effects. [...]

]]> http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-115 A look back at thalidomide – 50 years later | Goldenberg Heller Antognoli & Rowland Fri, 17 Feb 2012 14:27:42 +0000 http://goldenbergheller.com/?page_id=1000#comment-115 [...] tragedies, the United States Congress enacted the Kefauer-Harris amendments in 1962 requiring proof of safety and efficiency before a drug can receive approval for sale in the [...] [...] tragedies, the United States Congress enacted the Kefauer-Harris amendments in 1962 requiring proof of safety and efficiency before a drug can receive approval for sale in the [...]

]]> http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-103 Asthma and pre-term labor medication Terbutaline warning due to infant brain damage | Goldenberg Heller Antognoli & Rowland Thu, 01 Dec 2011 14:25:17 +0000 http://goldenbergheller.com/?page_id=1000#comment-103 [...] early contractions every year. The use of Terbutaline for use in pre-term labor and premature birth is not approved by the FDA. In fact, in 1997 the FDA issued its first warning concerning the potential dangers associated with [...] [...] early contractions every year. The use of Terbutaline for use in pre-term labor and premature birth is not approved by the FDA. In fact, in 1997 the FDA issued its first warning concerning the potential dangers associated with [...]

]]> http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-100 Bladder Cancer Warning For Diabetes Drug Actos | Goldenberg Heller Antognoli & Rowland Wed, 26 Oct 2011 13:56:07 +0000 http://goldenbergheller.com/?page_id=1000#comment-100 [...] with use of the diabetes drug Actos (pioglitazone), after analysis of a 5-year study of the drug by manufacturer Takeda [...] [...] with use of the diabetes drug Actos (pioglitazone), after analysis of a 5-year study of the drug by manufacturer Takeda [...]

]]> http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-95 Supreme Court decision protects makers of generic drugs | Goldenberg Heller Antognoli & Rowland Thu, 29 Sep 2011 01:39:10 +0000 http://goldenbergheller.com/?page_id=1000#comment-95 [...] a recent 5-4 decision in Pliva v. Mensing, the United States Supreme Court ruled that makers of generic drugs cannot be sued for failing to warn people of potentially dangerous side effects, as long as their [...] [...] a recent 5-4 decision in Pliva v. Mensing, the United States Supreme Court ruled that makers of generic drugs cannot be sued for failing to warn people of potentially dangerous side effects, as long as their [...]

]]>